Literature DB >> 1970924

Inhibition of cGMP-associated pulmonary arterial relaxation to H2O2 and O2 by ethanol.

T M Burke-Wolin1, M S Wolin.   

Abstract

We have recently suggested that relaxation of isolated precontracted intrapulmonary arteries from calves to H2O2 or O2 may involve the activation of guanylate cyclase by peroxide metabolism via catalase. In this study, ethanol, an agent that modulates peroxide metabolism by catalase and selectively inhibits the activation of guanylate cyclase by H2O2 but not by nitric oxide-related activators, was employed to further investigate the role of catalase in pulmonary arterial relaxation and guanylate cyclase activation by O2 and H2O2. In precontracted pulmonary arteries, ethanol reverses H2O2-elicited relaxation and increases in guanosine 3',5'-cyclic monophosphate (cGMP) tissue levels without affecting similar responses to nitroprusside. The pulmonary arteries employed in this study show a hypoxic contraction that is associated with decreases in cGMP levels, and reoxygenation produces a somewhat phasic relaxation and a marked increase in cGMP levels. Ethanol produces an O2 tension-dependent contraction and reverses relaxation to reoxygenation associated with inhibition of O2-elicited increases in cGMP levels. Thus ethanol appears to function as a mimic of hypoxia by inhibiting relaxations elicited by O2. These findings support a hypothesized role for H2O2-dependent activation of guanylate cyclase in O2-dependent regulation of pulmonary arterial smooth muscle tone.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1970924     DOI: 10.1152/ajpheart.1990.258.5.H1267

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

1.  Roles for redox mechanisms controlling protein kinase G in pulmonary and coronary artery responses to hypoxia.

Authors:  Boon Hwa Neo; Sharath Kandhi; Michael S Wolin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-16       Impact factor: 4.733

2.  Mediation of H2O2-induced vascular relaxation by endothelium-derived relaxing factor.

Authors:  L Bharadwaj; K Prasad
Journal:  Mol Cell Biochem       Date:  1995 Aug-Sep       Impact factor: 3.396

3.  Heme oxygenase-1 induction modulates hypoxic pulmonary vasoconstriction through upregulation of ecSOD.

Authors:  Mansoor Ahmad; Xiangmin Zhao; Melissa R Kelly; Sharath Kandhi; Oscar Perez; Nader G Abraham; Michael S Wolin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-07       Impact factor: 4.733

4.  Roles for soluble guanylate cyclase and a thiol oxidation-elicited subunit dimerization of protein kinase G in pulmonary artery relaxation to hydrogen peroxide.

Authors:  Boon Hwa Neo; Sharath Kandhi; Michael S Wolin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-08-13       Impact factor: 4.733

5.  Roles for Nox4 in the contractile response of bovine pulmonary arteries to hypoxia.

Authors:  Mansoor Ahmad; Melissa R Kelly; Xiangmin Zhao; Sharath Kandhi; Michael S Wolin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-03-19       Impact factor: 4.733

6.  Involvement of nitric oxide in the endothelium-dependent relaxation induced by hydrogen peroxide in the rabbit aorta.

Authors:  A Zembowicz; R J Hatchett; A M Jakubowski; R J Gryglewski
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

Review 7.  Activated oxygen metabolites as regulators of vascular tone.

Authors:  M S Wolin
Journal:  Klin Wochenschr       Date:  1991-12-15

8.  Effects of acute ingestion of ethanol on hemodynamics and hypoxic pulmonary vasoconstriction in dogs--role of leukotrienes.

Authors:  C Y Lu; D X Wang; S B Yu
Journal:  J Tongji Med Univ       Date:  1992

Review 9.  Oxidant and redox signaling in vascular oxygen sensing: implications for systemic and pulmonary hypertension.

Authors:  Sachin A Gupte; Michael S Wolin
Journal:  Antioxid Redox Signal       Date:  2008-06       Impact factor: 8.401

10.  Reactive oxygen species and the control of vascular function.

Authors:  Michael S Wolin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-01-16       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.